Publications by authors named "Helen Findlow"

Claim this Profile
I
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Kimberly Davis, Marta Valente Pinto, Nick J Andrews, David Goldblatt, Ray Borrow, Helen Findlow

Lancet Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study.
Timo Vesikari, Ray Borrow, Aino Forsten, Helen Findlow, Mandeep S Dhingra

Hum Vaccin Immunother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.
Marta Valente Pinto, Daniel O'Connor, Ushma Galal, Elizabeth A Clutterbuck, Hannah Robinson, Helen Findlow

Open Forum Infect Dis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
Seydou Yaro, Berthe-Marie Njanpop Lafourcade, Soumeya Ouangraoua, Aline Ouoba, Hervé Kpoda, Helen Findlow

Clin Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serogroup C disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.
Helen Findlow, Helen Campbell, Jay Lucidarme, Nick Andrews, Ezra Linley

Euro Surveill· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.
Wilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, Marcela F Pasetti, Mardi K Reymann, Helen Findlow

Lancet Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
Gunnstein Norheim, Judith E Mueller, Berthe-Marie Njanpop-Lafourcade, Isabelle Delrieu, Helen Findlow

Vaccine· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt.
Laura V Cooper, Rahamatou Moustapha Boukary, Abraham Aseffa, Wude Mihret, Jean-Marc Collard, Helen Findlow

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.
Alessandra R Souza, Claudia M Maruyama, Marco Aurélio P Sáfadi, Marta H Lopes, Raymundo S Azevedo, Helen Findlow

Vaccine· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
Olivier Manigart, Caroline Trotter, Helen Findlow, Abraham Assefa, Wude Mihret

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
Kelly Townsend-Payne, Shamez N Ladhani, Helen Findlow, Mary Slack, Ray Borrow

Vaccine· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
Olivier Manigart, Caroline Trotter, Helen Findlow, Abraham Aseffa, Wude Mihret

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?
Helen Findlow, Ray Borrow

Hum Vaccin Immunother· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Shamez N Ladhani, Nick J Andrews, Jo Southern, Christine E Jones, Gayatri Amirthalingam, Helen Findlow

Clin Infect Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Milagritos D Tapia, Helen Findlow, Olubukola T Idoko, Marie-Pierre Preziosi, Prasad S Kulkarni

Clin Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Aldiouma Diallo, Samba O Sow, Olubukola T Idoko, Siddhivinayak Hirve, Helen Findlow

Clin Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso.
Haoua Tall, Seydou Yaro, Hervé B N Kpoda, Soumeya Ouangraoua, Caroline L Trotter, Helen Findlow

Clin Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.
Nicole E Basta, Ray Borrow, Abdoulaye Berthe, Awa Traoré Eps Dembélé, Uma Onwuchekwa, Helen Findlow

Clin Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.
Gregory A Price, Aimee M Hollander, Brian D Plikaytis, Brian T Mocca, George Carlone, Helen Findlow

Clin Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.
Daniel Holme, Helen Findlow, Samba O Sow, Olubukola T Idoko, Marie-Pierre Preziosi

Clin Infect Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age.
David A Ishola, Nick Andrews, Pauline Waight, Chee-Fu Yung, Jo Southern, Helen Findlow, Jamie Findlow

Pediatr Infect Dis J· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers.
Jamie Findlow, Xilian Bai, Helen Findlow, Emma Newton, Ed Kaczmarski

Vaccine· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Nicholas Brodszki, Lillemor Skattum, Xilian Bai, Helen Findlow, Ray Borrow

Vaccine· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
Mildred A Iro, Ameneh Khatami, Andrew S J Marshall, David Pace, Merryn Voysey, Helen Findlow

Lancet Infect Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule.
Shamez N Ladhani, Nick J Andrews, Pauline Waight, Bassam Hallis, Mary Matheson, Helen Findlow

Vaccine· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis